Blue Sail Medical Co.,Ltd. (SHE:002382)
China · Delayed Price · Currency is CNY 7.08
+0.16 (2.31%)
May 8, 2026, 3:04 PM CST
Blue Sail Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 5,836 | 5,740 | 6,177 | 4,850 | 4,834 | 8,064 |
Other Revenue | - | - | 76.37 | 76.73 | 66.18 | 44.59 |
| 5,836 | 5,740 | 6,253 | 4,927 | 4,900 | 8,109 | |
Revenue Growth (YoY) | -7.75% | -8.21% | 26.91% | 0.54% | -39.56% | 3.04% |
Cost of Revenue | 4,808 | 4,840 | 5,262 | 4,393 | 4,481 | 4,382 |
Gross Profit | 1,028 | 899.28 | 991.03 | 533.82 | 419.17 | 3,726 |
Selling, General & Admin | 838.71 | 814.78 | 814.49 | 788.43 | 701.86 | 765.15 |
Research & Development | 245.81 | 254.42 | 341.92 | 290.75 | 352.49 | 438.52 |
Other Operating Expenses | 6.75 | -1.01 | 33.18 | 27.56 | 36.92 | 54.78 |
Operating Expenses | 1,091 | 1,068 | 1,212 | 1,125 | 1,093 | 1,279 |
Operating Income | -62.94 | -168.92 | -221.29 | -591.62 | -674.02 | 2,448 |
Interest Expense | - | - | -278.98 | -180.47 | -129.48 | -133.32 |
Interest & Investment Income | 15 | 16.8 | 30.38 | 40.67 | 294.44 | 81.06 |
Currency Exchange Gain (Loss) | - | - | 53.09 | 33.88 | 62.8 | -86.36 |
Other Non Operating Income (Expenses) | -388.99 | -330.66 | -5.72 | -6.69 | -12.26 | -27.4 |
EBT Excluding Unusual Items | -436.93 | -482.78 | -422.51 | -704.23 | -458.51 | 2,282 |
Impairment of Goodwill | - | - | - | - | - | -1,698 |
Gain (Loss) on Sale of Investments | -128.35 | 0.5 | -11.1 | 70.63 | -6.74 | 1,098 |
Gain (Loss) on Sale of Assets | -0.5 | -1.65 | -0.84 | -1.92 | 0.07 | -1.89 |
Asset Writedown | -119.56 | -177.2 | -6.29 | -21.47 | -6.94 | -370.68 |
Other Unusual Items | - | - | 39.14 | 34.38 | 66.26 | 38.08 |
Pretax Income | -685.34 | -661.14 | -401.6 | -622.61 | -405.86 | 1,347 |
Income Tax Expense | 174.71 | 137.28 | 63.32 | -54.25 | -33.54 | 191.65 |
Earnings From Continuing Operations | -860.05 | -798.41 | -464.92 | -568.36 | -372.32 | 1,156 |
Minority Interest in Earnings | 18.78 | 39.47 | 19.31 | - | 0 | 0 |
Net Income | -841.27 | -758.94 | -445.61 | -568.36 | -372.32 | 1,156 |
Net Income to Common | -841.27 | -758.94 | -445.61 | -568.36 | -372.32 | 1,156 |
Net Income Growth | - | - | - | - | - | -34.28% |
Shares Outstanding (Basic) | - | 999 | 1,013 | 1,015 | 1,006 | 1,023 |
Shares Outstanding (Diluted) | - | 999 | 1,013 | 1,015 | 1,006 | 1,051 |
Shares Change (YoY) | - | -1.40% | -0.21% | 0.86% | -4.22% | 3.36% |
EPS (Basic) | - | -0.76 | -0.44 | -0.56 | -0.37 | 1.13 |
EPS (Diluted) | - | -0.76 | -0.44 | -0.56 | -0.37 | 1.10 |
EPS Growth | - | - | - | - | - | -36.42% |
Free Cash Flow | -98.42 | -95.29 | -638.43 | -847.03 | -402.39 | -336.22 |
Free Cash Flow Per Share | - | -0.10 | -0.63 | -0.83 | -0.40 | -0.32 |
Dividend Per Share | - | - | - | - | 0.400 | - |
Gross Margin | 17.62% | 15.67% | 15.85% | 10.83% | 8.55% | 45.96% |
Operating Margin | -1.08% | -2.94% | -3.54% | -12.01% | -13.75% | 30.19% |
Profit Margin | -14.41% | -13.22% | -7.13% | -11.54% | -7.60% | 14.25% |
Free Cash Flow Margin | -1.69% | -1.66% | -10.21% | -17.19% | -8.21% | -4.15% |
EBITDA | 503.58 | 386.47 | 289.58 | -84.34 | -200.95 | 2,765 |
EBITDA Margin | 8.63% | 6.73% | 4.63% | -1.71% | -4.10% | 34.10% |
D&A For EBITDA | 566.52 | 555.39 | 510.87 | 507.27 | 473.06 | 317.51 |
EBIT | -62.94 | -168.92 | -221.29 | -591.62 | -674.02 | 2,448 |
EBIT Margin | -1.08% | -2.94% | -3.54% | -12.01% | -13.75% | 30.19% |
Effective Tax Rate | - | - | - | - | - | 14.22% |
Revenue as Reported | - | - | 6,253 | 4,927 | 4,900 | 8,109 |
Advertising Expenses | - | - | 80.29 | 88.32 | 54.61 | 24.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.